Monitoring of Safety and Tolerance of PICOPREP in Clinical Practice

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

3324 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-05-31

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Confirmation of Safety, Tolerance and Efficacy of PICOPREP in Clinical Practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bowel Cleanliness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PICOPREP treatment

PICOPREP powder for oral solution according to standard clinical practice

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients eligible for treatment with PICOPREP® for bowel cleansing prior to endoscopic examination or surgery

Exclusion Criteria

* Patients in which prescription of PICOPREP® is contraindicated

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Development Support

Role: STUDY_DIRECTOR

Ferring Pharmaceuticals

Review additional registry numbers or institutional identifiers associated with this trial.

000062

Identifier Type: -

Identifier Source: org_study_id

Monitoring of Safety and Tolerance of PICOPREP in Clinical Practice

Study Results

Basic Information

Brief Summary

Detailed Description

Conditions

Study Design

Study Groups

PICOPREP treatment

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Sponsors

Ferring Pharmaceuticals

Responsible Party

Principal Investigators

Clinical Development Support

Locations

Nemocnice Rudolfa a Stefanie

Nemocnice Blansko

Nemocnice Břeclav

Soukrmá ambulance

Děčínská nemocnice

Nemocnice Havlíčkův Brod

Fakultní nemocnice Hradec Králové

Nemocnice Jablonec

Nemocnice Jihlava

Privátní GE

FN Olomouc

FN Bulovka

Privátní GE Praha 4

Sanatorium Sv.Anny

Thomayerova nemocnice

Všeobecná fakutlní nemocnice

Nemocnice Příbram

Lužická nemocnice

Nemocnice Tábor

Nemocnice Teplice

Ústecká poliklinika

Nemocnice Znojmo

Countries

Other Identifiers

000062